Financial statements Organic & Innovation Laboratorium
Balance sheet data of ORGANIC & INNOVATION LABORATORIUM
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 175 500,31 | 376 169,79 | 508 917,60 | 701 759,24 | 714 806,31 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
B. Current assets | 175 500,31 | 376 169,79 | 508 917,60 | 701 759,24 | 714 806,31 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 175 500,31 | 376 169,79 | 508 917,60 | 701 759,24 | 714 806,31 |
A. Equity | 3 531,36 | 69 107,09 | 149 348,74 | 17 921,29 | -33 056,93 |
B. Liabilities and provisions for liabilities | 171 968,95 | 307 062,70 | 359 568,86 | 683 837,95 | 747 863,24 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 171 378,95 | 307 062,70 | 359 568,86 | 683 837,95 | 747 863,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.